Study guide
7.3 Seizures, Status Epilepticus & Epilepsy Management
Professional and Linguistic Assessments Board Part 1 PLAB 1
Track your progress as you read
Finished sections get a check mark.
1 Introduction
About the PLAB 1 Exam
2 Chapter 1: Acute Medicine, Resuscitation & Clinical Emergencies
1.1 The ABCDE Approach, Adult Resuscitation & Shock 1.2 Sepsis, Sepsis Six Protocol & Septic Shock 1.3 Anaphylaxis & Acute Airway Emergencies 1.4 Clinical Toxicology & Acute Poisoning 1.5 Major Trauma, Head Injury, Burns & Environmental Emergencies
3 Chapter 2: Cardiovascular Medicine & Vascular Disorders
2.1 Acute Coronary Syndromes (STEMI & NSTEMI/Unstable Angina) 2.2 Heart Failure & Cardiogenic Shock 2.3 Cardiac Arrhythmias & Syncope 2.4 Hypertension, Valvular Heart Disease & Aortic Emergencies 2.5 Infective Endocarditis, Pericardial Disease, Myocarditis & Cardiomyopathies 2.6 Peripheral Arterial Disease, Aortic Aneurysm & Venous Disease
4 Chapter 3: Respiratory Medicine
3.1 Asthma: Diagnostic Criteria, Chronic Stepping & Acute Exacerbations 3.2 COPD: Staging, Long-Term Management & Acute Exacerbations 3.3 Pneumonia & Lower Respiratory Tract Infections 3.4 Venous Thromboembolism, Pleural Disease & Pneumothorax 3.5 Lung Cancer, Interstitial & Suppurative Lung Disease, Sleep Apnoea & Respiratory Failure
5 Chapter 4: Gastroenterology, Hepatobiliary & General Surgery
4.1 Upper Gastrointestinal Bleeding & Dyspepsia 4.2 Lower Gastrointestinal Bleeding, IBD & Colorectal Malignancy 4.3 Acute Abdomen, Bowel Obstruction & Perforation 4.4 Hepatobiliary Disease, Cirrhosis & Acute Pancreatitis 4.5 Functional, Malabsorptive & Infective Bowel Disorders, Anorectal Disease, Hernias & MASLD
6 Chapter 5: Renal Medicine, Urology & Fluid/Electrolyte Balance
5.1 Acute Kidney Injury & KDIGO Staging 5.2 Chronic Kidney Disease & Glomerular Disorders 5.3 Electrolyte Emergencies: Potassium, Sodium & Calcium 5.4 Urology: Urinary Tract Infections, Renal Colic & Urinary Retention 5.5 Urological Cancers, Prostate Disease & Scrotal Emergencies
7 Chapter 6: Endocrinology & Metabolic Medicine
6.1 Diabetes Mellitus: Diagnostic Criteria & Chronic Management 6.2 Diabetic Emergencies: DKA & Hyperosmolar Hyperglycaemic State 6.3 Thyroid Disorders: Hypothyroidism, Thyrotoxicosis & Thyroid Storm 6.4 Adrenal & Pituitary Disorders: Addisonian Crisis & Pituitary Disease
8 Chapter 7: Neurology & Neurosciences
7.1 Acute Stroke, TIA & Intracranial Haemorrhage 7.2 Acute & Chronic Headaches, Giant Cell Arteritis & CNS Infections 7.3 Seizures, Status Epilepticus & Epilepsy Management 7.4 Neuromuscular Disorders & Movement Disorders 7.5 Raised Intracranial Pressure, Brain Tumours, Cranial Nerve Lesions & Spinal Cord Disorders
9 Chapter 8: Psychiatry & Mental Health
8.1 Affective Disorders: Depression, Bipolar Disorder & Suicide Risk Assessment 8.2 Psychosis, Schizophrenia & Acute Agitation 8.3 Cognitive Disorders, Substance Misuse & the Mental Health Act 8.4 Anxiety Disorders, OCD, PTSD, Eating Disorders, Personality Disorders & Somatic Presentations 8.5 Perinatal, Child & Adolescent and Neurodevelopmental Mental Health
10 Chapter 9: Obstetrics, Gynaecology & Sexual Health
9.1 Early Pregnancy: Miscarriage & Ectopic Pregnancy 9.2 Antenatal & Peripartum Emergencies: Pre-Eclampsia & Haemorrhage 9.3 Common Gynaecological Presentations & Gynaecological Oncology 9.4 Contraception, Emergency Contraception & Sexually Transmitted Infections 9.5 Routine Antenatal Care, Labour & Obstetric Emergencies 9.6 Menopause & HRT, Subfertility, Prolapse & Urinary Incontinence
11 Chapter 10: Paediatrics & Child Health
10.1 The Febrile Child, Sepsis & Meningococcal Disease 10.2 Paediatric Respiratory Distress: Croup, Bronchiolitis & Wheeze 10.3 Paediatric Abdominal Emergencies, Dehydration & Neonatal Jaundice 10.4 Child Safeguarding, Non-Accidental Injury & Developmental Milestones 10.5 Neonatology & Congenital Heart Disease 10.6 Paediatric Orthopaedics, Growth, Childhood Cancer & Common Chronic Problems
12 Chapter 11: Musculoskeletal Medicine & Rheumatology
11.1 Inflammatory Arthropathies & Connective Tissue Diseases 11.2 Crystal Arthropathies (Gout & Pseudogout) & Septic Arthritis 11.3 Osteoporosis, Common Fractures & Orthopaedic Emergencies 11.4 Osteoarthritis, Low Back Pain, Polymyalgia Rheumatica, Fibromyalgia & Soft Tissue Disorders
13 Chapter 12: Dermatology, ENT & Ophthalmology
12.1 Common Dermatoses & Dermatological Emergencies 12.2 ENT Presentations: Infections, Epistaxis, Vertigo, Hearing Loss & Head and Neck Lumps 12.3 The Acute Red Eye: Glaucoma, Uveitis & Keratitis 12.4 Sudden & Gradual Vision Loss, Retinal Disorders & the Visual Pathway 12.5 Skin Infections, Infestations, Childhood Rashes & Skin Cancer
14 Chapter 13: Haematology, Oncology & Palliative Care
13.1 Anaemias & Blood Transfusion Medicine 13.2 Haematological Malignancies: Leukaemias, Lymphomas & Myeloma 13.3 Haemostasis, Coagulation Disorders & Anticoagulant Reversal 13.4 Oncological Emergencies & Palliative Symptom Management 13.5 Breast Disease, Cancer Screening & Suspected Cancer Referral
15 Chapter 14: Perioperative Care, Safe Prescribing & Clinical Pharmacology
14.1 Preoperative Assessment & Perioperative Medication Management 14.2 Postoperative Complications & Fluid Therapy 14.3 High-Risk Medications & Therapeutic Drug Monitoring 14.4 Safe Prescribing Principles & Antimicrobial Stewardship
16 Chapter 15: Medical Ethics, Law & UK Clinical Practice
15.1 GMC Good Medical Practice, Professionalism, Teamwork & Quality Improvement 15.2 Consent, Capacity & the Mental Capacity Act 2005 15.3 Confidentiality, Statutory Reporting & DVLA Regulations 15.4 End-of-Life Decisions, DNACPR, Organ Donation, Adult Safeguarding & Domestic Abuse
17 Chapter 16: Infectious Diseases, Travel Medicine & Infection Prevention
16.1 Tuberculosis, HIV, Hepatitis B & C and Needlestick Injuries 16.2 Fever in the Returning Traveller, Zoonoses, Notifiable Diseases & Infection Prevention
18 Chapter 17: Older Adults, Population Health, Genetics & Clinical Imaging
17.1 Frailty, Falls, Polypharmacy, Continence & Pressure Ulcers 17.2 Medical Statistics, Diagnostic Tests & Critical Appraisal 17.3 Public Health, Screening Principles, Health Inequalities & Health Promotion 17.4 Genetics, Genomics & Pharmacogenomics 17.5 Clinical Imaging: Choosing Tests, Radiation Safety & Interpreting X-rays
7.3 Seizures, Status Epilepticus & Epilepsy Management
Key Takeaways Explain This Topic AI
Seizures are classified into focal (aware or impaired awareness, localized to temporal, frontal, parietal, or occipital lobes) and generalised (bilateral networks, including tonic-clonic, absence, and myoclonic).
Convulsive status epilepticus is a medical emergency requiring stepped escalation: Step 1 (0–5 min: ABCDE, oxygen, glucose check), Step 2 (5–10 min: IV lorazepam 4 mg or buccal midazolam 10 mg, repeated once if needed), Step 3 (20–40 min: IV levetiracetam, sodium valproate, or phenytoin), and Step 4 (>40 min: ICU transfer, intubation, and general anaesthesia).
Long-term anti-seizure monotherapy is guided by seizure type and reproductive potential (NICE NG217): lamotrigine or levetiracetam for focal seizures; valproate for generalised seizures only in boys, men and women unable to have children (MHRA two-specialist rule under 55); ethosuximide for absence seizures.
A first unprovoked seizure mandates a 12-lead ECG, metabolic bloods, MRI brain, and specialist neurology review within 2 weeks; under DVLA regulations, driving must cease for a minimum of 6 months (extended to 12 months if high recurrence risk or established epilepsy).
Last updated: October 2026
Seizures, Status Epilepticus & Epilepsy Management
Epilepsy is defined by the International League Against Epilepsy (ILAE) as a disease characterized by an enduring predisposition to generate epileptic seizures, typically diagnosed after two unprovoked seizures occurring >24 hours apart, or one unprovoked seizure with an estimated recurrence risk >60% over 10 years.
Seizure Classification & Clinical Semiologies
Seizures are divided fundamentally based on their onset into focal (originating within networks limited to one cerebral hemisphere) and generalised (originating at some point within and rapidly engaging bilaterally distributed networks).
1. Focal Seizures
Focal Aware Seizures (Simple Partial): Consciousness remains entirely intact throughout the episode; subjective aura or motor/sensory focal activity experienced.
Focal Impaired Awareness Seizures (Complex Partial): Consciousness or awareness is altered or impaired at any point during the attack; patients cannot respond normally and exhibit post-ictal amnesia.
Anatomical Lobar Localization:
Temporal Lobe Seizures (the most common focal epilepsy in adults): Often caused by hippocampal sclerosis. Present with rising epigastric aura ('butterflies in stomach'), affective disturbances (sudden intense fear, euphoria, déjà vu / jamais vu), olfactory/gustatory hallucinations (smelling burnt rubber), and prominent motor automatisms (involuntary lip-smacking, chewing, repetitive swallowing, or purposeless hand fumbling). Characterised by prolonged post-ictal confusion and amnesia.
Frontal Lobe Seizures: Typically brief (<30–60 seconds), frequent, occurring predominantly during sleep. Characterized by prominent motor manifestations: asymmetric tonic posturing, 'fencing posture', head and eye deviation away from the epileptogenic focus (adversive), violent bipedal kicking or pelvic thrusting (hypermotor automatisms), or the Jacksonian March (clonic jerking marching sequentially from the distal fingers up the arm to the face).
Parietal Lobe Seizures: Sensory phenomena including contralateral tingling, numbness, dysaesthesias, or distorted body schema illusions.
Occipital Lobe Seizures: Elementary visual phenomena such as flashing lights, brightly coloured geometric shapes, transient scotomas, or oculomotor nystagmus.
2. Generalised Seizures
Generalised Tonic-Clonic Seizures (GTC):
Tonic Phase (10–20 sec): Sudden loss of consciousness, sustained generalised muscle contraction, ictal cry (forced air expulsion across contracting vocal cords), respiratory arrest with cyanosis, and tongue biting (characteristically along the lateral border of the tongue).
Clonic Phase (30–90 sec): Synchronous rhythmic, violent jerking of all four limbs, hypersalivation, urinary/faecal incontinence, and autonomic activation (tachycardia, diaphoresis).
Post-ictal Phase: Flaccid coma gradually transitioning to deep sleep, confusion, headache, generalized myalgias, and transient Todd's paresis.
Absence Seizures (Typical Petit Mal):
Exclusively onset in childhood (ages 4–10 years). Characterised by brief (5–15 seconds) sudden cessation of activity and vacant staring, with immediate resumption of pre-ictal activity without any post-ictal confusion.
Provoked reproducibly in clinic by hyperventilation for 3 minutes.
Electroencephalogram (EEG) demonstrates pathognomonic synchronous 3 Hz spike-and-wave discharges across all leads.
Myoclonic Seizures:
Brief, shock-like involuntary muscle twitches without impairment of consciousness.
Hall-mark of Juvenile Myoclonic Epilepsy (JME) : adolescent onset presenting with sudden morning myoclonic jerks (e.g. dropping a cup of tea or toothbrush), provoked by sleep deprivation and alcohol intake, with generalized spike-and-wave discharges on EEG.
Atonic ('Drop Attacks') & Tonic Seizures: Sudden loss of postural tone causing catastrophic falls, commonly seen in severe childhood epileptic encephalopathies (such as Lennox-Gastaut syndrome).
Emergency Management of Convulsive Status Epilepticus
Convulsive status epilepticus is defined by the ILAE as a continuous convulsive seizure lasting ≥5 minutes (Time t1) , or two or more discrete seizures between which the patient does not fully regain consciousness. Time t2 is defined as 30 minutes , beyond which severe neuronal damage, pharmacoresistance, and systemic decompensation ensue.
Step 1: Immediate Triage & Resuscitation (0–5 Minutes)
Apply ABCDE framework: secure airway, position in lateral recovery position, administer high-flow 100% oxygen (15 L/min via non-rebreather mask), attach pulse oximetry, ECG, and blood pressure monitors.
Secure wide-bore intravenous access and take bloods (electrolytes, calcium, magnesium, renal and liver function, FBC, anticonvulsant drug levels, venous blood gas).
Check capillary blood glucose immediately: If blood glucose is <4.0 mmol/L, administer 100 mL of 10% or 20% glucose IV. In patients with suspected alcohol misuse or malnutrition, administer intravenous Pabrinex (thiamine) before or concurrently with glucose to avoid precipitating acute Wernicke's encephalopathy.
Step 2: Early Status Epilepticus (5–10 Minutes) — First-Line Benzodiazepines
If IV Access Available: Administer Intravenous Lorazepam 4 mg (0.1 mg/kg in children) as a slow IV bolus over 2 minutes.
If IV Access Unavailable / Pre-hospital: Administer Buccal Midazolam 10 mg (instilled between gums and cheek) OR Rectal Diazepam 10 mg .
Failure to Terminate at 10 Minutes: If convulsive seizure activity persists 5–10 minutes after the first dose, administer a single repeat dose of the same benzodiazepine (e.g. repeat IV Lorazepam 4 mg).
Strict Rule: Administer a maximum of two benzodiazepine doses in total to minimize the risk of profound respiratory depression and hypotension.
Step 3: Established Status Epilepticus (20–40 Minutes) — Second-Line IV Anti-Seizure Medications
If convulsions persist despite two adequate doses of benzodiazepines, immediately commence a second-line non-sedating IV anti-seizure medication infused over 10–15 minutes:
Intravenous Levetiracetam (First Choice in many UK centres): Dose 60 mg/kg (maximum dose 4500 mg) infused over 10 minutes. Preferred due to rapid infusion time, superior cardiac safety, and minimal drug interactions.
Intravenous Sodium Valproate: Dose 40 mg/kg (maximum dose 3000 mg) infused over 5–10 minutes.
Intravenous Phenytoin: Dose 20 mg/kg infused over 20–30 minutes.
Mandatory Phenytoin Precautions: Infusion rate must never exceed 50 mg/minute in adults.
Continuous ECG and blood pressure monitoring are mandatory during infusion due to the high risk of severe hypotension, heart block, and fatal cardiac arrhythmias.
Must only be mixed with 0.9% normal saline (precipitates in glucose solutions).
Extravasation causes severe skin necrosis and limb ischaemia ('purple glove syndrome').
Step 4: Refractory Status Epilepticus (>40–60 Minutes)
Convulsions continuing despite adequate first-line benzodiazepine and second-line IV anti-seizure therapy constitute refractory status epilepticus.
Immediate ICU Transfer: Patient must be urgently transferred to the Intensive Care Unit for endotracheal intubation, mechanical ventilation, invasive arterial line monitoring, and continuous EEG monitoring.
General Anaesthesia: Initiate titratable continuous IV anaesthetic infusions: Propofol , Midazolam , or Thiopental sodium titrated to achieve burst suppression on continuous EEG for 12–24 hours.
Long-Term Anti-Seizure Medication (ASM) Selection
Current NICE guidelines emphasize monotherapy tailored to seizure semiology, patient sex, age, and comorbidity profile.
Seizure Classification First-Line Monotherapy Alternative / Second-Line Options Crucial Contraindications & Clinical Pearls
Focal Seizures (with or without secondary generalization) Lamotrigine OR Levetiracetam Carbamazepine, Oxcarbazepine, Lacosamide, Zonisamide Carbamazepine induces hepatic CYP3A4, reducing oral contraceptive efficacy; causes SIADH hyponatraemia and Stevens-Johnson syndrome
Generalised Tonic-Clonic Sodium valproate for boys, men and women unable to have children (NICE NG217; under-55s now need two-specialist agreement, MHRA 2024); Lamotrigine or Levetiracetam for women and girls able to have children Clobazam, Topiramate, Perampanel (specialist) Valproate is avoided in women and girls able to have children because of severe teratogenicity
Absence Seizures Ethosuximide Sodium Valproate (if PPP met) Never use Carbamazepine, Phenytoin, Gabapentin, or Pregabalin ; sodium channel blockers exacerbate absence seizures!
Myoclonic Seizures (e.g. JME) Sodium valproate for boys, men and women unable to have children (MHRA rules apply); Levetiracetam for women and girls able to have children Topiramate, Brivaracetam (specialist) Never use Carbamazepine or Phenytoin ; they significantly worsen myoclonic jerks and can precipitate status
Caution
MHRA Safety Mandate: Strict Sodium Valproate Restrictions: Sodium valproate is the most potent human teratogen among anti-seizure medications, carrying an approximate 10% risk of major congenital malformations (neural tube defects like spina bifida, cardiac anomalies, craniofacial clefts) and a 30–40% risk of persistent neurodevelopmental disorders, cognitive delay, and autism spectrum disorder .
Since January 2024, MHRA regulations state that valproate must not be started in any new patient, male or female, younger than 55 unless two specialists independently consider and document that no other effective or tolerated treatment exists, or that the reproductive risks do not apply. Women and girls able to have children who take valproate must be in the Pregnancy Prevention Programme (PPP) , with highly effective contraception and an annual risk acknowledgement form.